In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Sanjiv Bhasin of IIFL shared his reading and outlook on the market and also gave recommendations on various stocks.
Edelweiss recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 820 in its research report dated February 03, 2017.
Religare is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated February 03, 2017.
ICICI Direct is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1155 in its research report dated February 06, 2017.
In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Prakash Diwan of Altamount Capital Management shared his reading and outlook on the market and also gave recommendations on various stocks.
Axis Direct is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated December 27, 2016.
Axis Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1040 in its research report dated December 06, 2016.
Axis Direct is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1040 in its research report dated November 01, 2016.
Religare is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated October 28, 2016.
ICICI Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated November 01, 2016.
Axis Direct has recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 900 in its research report dated August 16, 2016.
Edelweiss recommended hold rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 12, 2016.
Edelweiss recommended hold rating on Glenmark with a target price of Rs 780 in its research report dated May 13, 2016.
Axis securities has recommended hold rating on Glenmark with a target price of Rs 800 in its research report dated February 1, 2016.
Prabhudas Lilladher is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 1,186 in its research report dated January 29, 2016
Religare is bullish on Glenmark and has recommended buy rating on the stock with a target price of Rs 1040 in its research report dated January 29, 2016.
ICICIDirect is bullish on Glenmark and has recommended buy rating on the stock with a target price of Rs 975 in its research report dated January 29, 2016.
Edelweiss has recommended hold rating on Glenmark Pharma with a target price of Rs 875 in its research report dated October 30, 2015.
Watch the interview of technical analyst, SP Tulsian of sptulsian.com with Latha Venkatesh and Sonia Shenoy of CNBC-TV18. He shared his reading and outlook on the market and also gave recommendations on various stocks.
Prabhudas Lilladher is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 1186 in its research report dated October 8, 2015.
Emkay is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target price of Rs 1085 in its research report dated September 03, 2015.
Prabhudas Lilladher is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 1186, in its research report dated August 01, 2015.
ICICIdirect.com has recommended to hold Glenmark Pharma with a target price of Rs 1000, in its research report dated August 3, 2015.
Brokerage house Prabhudas Lilladher is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 1186 in its research report dated April 01, 2015.
Brokerage house Firstcall Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 913 in its research report dated December 04, 2014.